]>
IRCT2017102418858N7 IRCT 2017-11-13 University of Medical Sciences and Health Services, Yazd The effect of natural sweetener lacrithosis on blood glucose in type 2 diabetic patients Comparison of average blood sugar in people with type II diabetes natural sweetener consumers Lacriroze and control group-clinical trial 2017-11-06 anticipated 30 Complete https://irct.ir/trial/16994 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention. 2 Non-insulin-dependent diabetes mellitus. Intervention 1: Sucrose and Lacritoze. Intervention 2: Lacritoze. Intervention 3: Sucrose.
public Mozhghan Modarresi
Iran, Yazd, Diabete Research Center
Yazd Iran (Islamic Republic of) +98 35 3728 0226 mdmodarresi@gmail.com Yazd University of Medical Science scientific Reza Nazemian
Talar honar alley, Bahonar square, Yazd, Iran
Yazd Iran (Islamic Republic of) +98 35 3728 0226 reza46ny@yahoo.com Yazd University of Medical Science Iran (Islamic Republic of) Inclusion criteria: Type 2 diabetes, the age group of 30-60, fasting blood glucose less than 200 mg / dl, HbA1C≤9≥7, are under the control of oral hypoglycemic or dietary medications, are not treated with insulin. Sugar in the diet of the patient. Drugs for blood sugar, blood lipids and blood pressure did not change during the past month, having a medical record at the Yazd diabetes research center, a willingness to participate in research. Exclusion criteria: Patient's inability to follow-up (life in the city, end stage, patients who need to control high blood sugar due to complications of diabetes, those who have a severe change in their calories and their activity, people with deficiency of Lactose, pregnancy And lactation, patients with severe infections or endocrine disorders, those with acute illnesses, people with liver and kidney failure, patients with diabetes complications (nephropathy, neuropathy, retinopathy), BMI≥35 30 years 60 years Both E11 Lifestyle Lifestyle Placebo Sucrose and Lacritoze Lacritoze Sucrose FBS. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. 2hPP. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. Fructosamine. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. Insulin. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. Urea. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. Cr. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. SGOT. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. SGPT. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test. BMI. Timepoint: Before the intervention, After the intervention. Method of measurement: Balance and meter. Digestive complications. Timepoint: Before the intervention, After the intervention. Method of measurement: Questionare. University of Medical Sciences and Health Services, Yazd Approved 2017-08-15 Ethics committee of Yazd University of Medical Science Bahonar square, Yazd, Iran Yazd Iran (Islamic Republic of)